Exercise

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA Approval
FDA sign
FDA Approval
FDA Approves Orforglipron (Foundayo) for Chronic Weight Management
04/02/2026
Anthony Calabro, MA
The FDA approved oral GLP-1 orforglipron (Foundayo) for weight management without food or water restrictions.
04/02/2026
FDA Alert
patient holding pills
FDA Alert
FDA Approves Oral Semaglutide Pill for Chronic Weight Management
12/23/2025
Anthony Calabro, MA
The FDA has cleared a once-daily oral semaglutide treatment for adults with obesity or overweight and weight-related conditions, based on phase 3 OASIS 4 trial results demonstrating significant mean weight...
12/23/2025